Literature DB >> 30850029

Extracellular S100A11 Plays a Critical Role in Spread of the Fibroblast Population in Pancreatic Cancers.

Hitoshi Takamatsu1, Ken-Ichi Yamamoto1, Nahoko Tomonobu1, Hitoshi Murata1, Yusuke Inoue2, Akira Yamauchi3, I Wayan Sumardika1, Youyi Chen1, Rie Kinoshita1, Masahiro Yamamura4, Hideyo Fujiwara5, Yosuke Mitsui1, Kota Araki1, Junichiro Futami6, Ken Saito7, Hidekazu Iioka7, I Made Winarsa Ruma8, Endy Widya Putranto9, Masahiro Nishibori10, Eisaku Kondo7, Yasuhiko Yamamoto11, Shinichi Toyooka12, Masakiyo Sakaguchi1.   

Abstract

The fertile stroma in pancreatic ductal adenocarcinomas (PDACs) has been suspected to greatly contribute to PDAC progression. Since the main cell constituents of the stroma are fibroblasts, there is crosstalking(s) between PDAC cells and surrounding fibroblasts in the stroma, which induces a fibroblast proliferation burst. We have reported that several malignant cancer cells including PDAC cells secrete a pronounced level of S100A11, which in turn stimulates proliferation of cancer cells via the receptor for advanced glycation end products (RAGE) in an autocrine manner. Owing to the RAGE+ expression in fibroblasts, the extracellular abundant S100A11 will affect adjacent fibroblasts. In this study, we investigated the significance of the paracrine axis of S100A11-RAGE in fibroblasts for their proliferation activity. In in vitro settings, extracellular S100A11 induced upregulation of fibroblast proliferation. Our mechanistic studies revealed that the induction is through RAGE-MyD88-mTOR-p70 S6 kinase upon S100A11 stimulation. The paracrine effect on fibroblasts is linked mainly to triggering growth but not cellular motility. Thus, the identified pathway might become a potential therapeutic target to suppress PDAC progression through preventing PDAC-associated fibroblast proliferation.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30850029     DOI: 10.3727/096504018X15433161908259

Source DB:  PubMed          Journal:  Oncol Res        ISSN: 0965-0407            Impact factor:   5.574


  7 in total

1.  The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis.

Authors:  Kota Araki; Rie Kinoshita; Nahoko Tomonobu; Yuma Gohara; Shuta Tomida; Yuta Takahashi; Satoru Senoo; Akihiko Taniguchi; Junko Itano; Ken-Ichi Yamamoto; Hitoshi Murata; Ken Suzawa; Kazuhiko Shien; Hiromasa Yamamoto; Mikio Okazaki; Seiichiro Sugimoto; Kouichi Ichimura; Masahiro Nishibori; Nobuaki Miyahara; Shinichi Toyooka; Masakiyo Sakaguchi
Journal:  J Mol Med (Berl)       Date:  2020-11-09       Impact factor: 4.599

2.  Construction for Long Non-Coding RNA (lncRNA)-Associated Competing Endogenous RNA (ceRNA) Network in Human Retinal Detachment (RD) with Proliferative Vitreoretinopathy (PVR).

Authors:  Ke Yao; Yixian Yu; Hong Zhang
Journal:  Med Sci Monit       Date:  2020-02-27

3.  Tissue mRNA for S100A4, S100A6, S100A8, S100A9, S100A11 and S100P Proteins in Colorectal Neoplasia: A Pilot Study.

Authors:  Eva Peterova; Jan Bures; Paula Moravkova; Darina Kohoutova
Journal:  Molecules       Date:  2021-01-14       Impact factor: 4.411

4.  S100A11 (calgizzarin) is released via NETosis in rheumatoid arthritis (RA) and stimulates IL-6 and TNF secretion by neutrophils.

Authors:  Adéla Navrátilová; Viktor Bečvář; Jiří Baloun; Dres Damgaard; Claus Henrik Nielsen; David Veigl; Karel Pavelka; Jiří Vencovský; Ladislav Šenolt; Lucie Andrés Cerezo
Journal:  Sci Rep       Date:  2021-03-16       Impact factor: 4.379

5.  Upregulation of Mobility in Pancreatic Cancer Cells by Secreted S100A11 Through Activation of Surrounding Fibroblasts.

Authors:  Yosuke Mitsui; Nahoko Tomonobu; Masami Watanabe; Rie Kinoshita; I Wayan Sumardika; Chen Youyi; Hitoshi Murata; Ken-Ichi Yamamoto; Takuya Sadahira; Acosta Gonzalez Herik Rodrigo; Hitoshi Takamatsu; Kota Araki; Akira Yamauchi; Masahiro Yamamura; Hideyo Fujiwara; Yusuke Inoue; Junichiro Futami; Ken Saito; Hidekazu Iioka; Eisaku Kondo; Masahiro Nishibori; Shinichi Toyooka; Yasuhiko Yamamoto; Yasutomo Nasu; Masakiyo Sakaguchi
Journal:  Oncol Res       Date:  2019-04-17       Impact factor: 5.574

6.  High Expression of GSDMC Is Associated with Poor Survival in Kidney Clear Cell Cancer.

Authors:  Yun-Qian Cui; Fei Meng; Wen-Li Zhan; Zhou-Tong Dai; Xinghua Liao
Journal:  Biomed Res Int       Date:  2021-11-05       Impact factor: 3.411

7.  Upregulation of S100A10 in metastasized breast cancer stem cells.

Authors:  Hisano Yanagi; Takashi Watanabe; Tatsunori Nishimura; Takanori Hayashi; Seishi Kono; Hitomi Tsuchida; Munetsugu Hirata; Yuko Kijima; Shintaro Takao; Seiji Okada; Motoshi Suzuki; Kazuyoshi Imaizumi; Kenji Kawada; Hironobu Minami; Noriko Gotoh; Yohei Shimono
Journal:  Cancer Sci       Date:  2020-10-11       Impact factor: 6.716

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.